Novel polypeptides having sequence similarity to GDNFR and nucleic acids encoding the same

Details for Australian Patent Application No. 2003213166 (hide)

Owner Genentech, Inc.

Inventors Zhang, Zemin; Wood, William I; Seshagiri, Somasekar; Stinson, Jeremy; Grimaldi, Christopher J

Agent Griffith Hack

Pub. Number AU-B-2003213166

PCT Number PCT/US03/05169

PCT Pub. Number WO2003/076569

Priority 60/361,995 05.03.02 US

Filing date 18 February 2003

Wipo publication date 22 September 2003

Acceptance publication date 3 July 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

24 July 2003 Complete Application Filed

  Priority application(s): 60/361,995 05.03.02 US

30 October 2003 Application Open to Public Inspection

  Published as AU-B-2003213166

3 July 2008 Application Accepted

  Published as AU-B-2003213166

30 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003213167-SEQUENCE ANALYSIS OF THE TETRAVALENT ROTAVIRUS VACCINE

2003213165-FOLDED LONGITUDINAL TORSIONAL HINGE FOR GIMBALED MEMS MIRROR HINGE